Woolf; Tod
Patent Applications and Registrations
Patent applications and USPTO patent grants for Woolf; Tod.The latest application filed is for "oligonucleotide compositions with enhanced efficiency".
- Woolf; Tod - Sudbury MA
- Woolf; Tod - Natic MA
- Woolf; Tod - Natick MA
- Woolf; Tod - Watertown MA
| Patent | Date |
|---|---|
| Oligonucleotide compositions with enhanced efficiency Grant 10,626,398 - Woolf , et al. | 2020-04-21 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20190316138 - Woolf; Tod ; et al. | 2019-10-17 |
| Oligonucleotide compositions with enhanced efficiency Grant 10,196,640 - Woolf , et al. Fe | 2019-02-05 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20190017051 - WOOLF; Tod ; et al. | 2019-01-17 |
| Double-stranded Oligonucleotides App 20190002880 - Woolf; Tod ; et al. | 2019-01-03 |
| Double-stranded oligonucleotides Grant 10,106,793 - Woolf , et al. October 23, 2 | 2018-10-23 |
| Oligonucleotide compositions with enhanced efficiency Grant 10,036,025 - Woolf , et al. July 31, 2 | 2018-07-31 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20180087056 - WOOLF; Tod ; et al. | 2018-03-29 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20170321219 - WOOLF; Tod ; et al. | 2017-11-09 |
| Oligonucleotide compositions with enhanced efficiency Grant 9,796,978 - Woolf , et al. October 24, 2 | 2017-10-24 |
| Oligonucleotide compositions with enhanced efficiency Grant 9,777,275 - Woolf , et al. October 3, 2 | 2017-10-03 |
| Double-stranded Oligonucleotides App 20170137816 - WOOLF; Tod ; et al. | 2017-05-18 |
| Double-stranded oligonucleotides Grant 9,592,250 - Woolf , et al. March 14, 2 | 2017-03-14 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20150099797 - WOOLF; Tod ; et al. | 2015-04-09 |
| Double-stranded Oligonucleotides App 20150057333 - WOOLF; TOD ; et al. | 2015-02-26 |
| Double-stranded oligonucleotides Grant 8,815,821 - Woolf August 26, 2 | 2014-08-26 |
| Oligonucleotide Compositions With Enhanced Efficiency App 20130303586 - Woolf; Tod ; et al. | 2013-11-14 |
| SENSE mRNA THERAPY App 20090093433 - Woolf; Tod ; et al. | 2009-04-09 |
| Double-Stranded Oligonucleotides App 20090023216 - Woolf; Tod | 2009-01-22 |
| Chemically modified double stranded nucleic acid molecules App 20050176018 - Thompson, James ; et al. | 2005-08-11 |
| Antisense oligomers App 20040224913 - Woolf, Tod | 2004-11-11 |
| Nucleic acid molecules with novel chemical compositions capable of modulating gene expression Grant 6,673,611 - Thompson , et al. January 6, 2 | 2004-01-06 |
| Nucleic acid molecules with novel chemical compositions capable of modulating gene expression App 20020142980 - Thompson, James ; et al. | 2002-10-03 |
| Respiratory syncytial virus ribozymes Grant 5,693,532 - McSwiggen , et al. December 2, 1 | 1997-12-02 |
| SEC | 0001426274 | Woolf Tod |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 